Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity

被引:16
作者
Weber, Daniela D. [1 ]
Aminzadeh-Gohari, Sepideh [1 ]
Thapa, Maheshwor [2 ]
Redtenbacher, Anna-Sophia [1 ]
Catalano, Luca [1 ]
Capeloa, Tania [3 ]
Vazeille, Thibaut [3 ]
Emberger, Michael [4 ]
Felder, Thomas K. [5 ]
Feichtinger, Rene G. [1 ]
Koelblinger, Peter [6 ]
Dallmann, Guido [2 ]
Sonveaux, Pierre [3 ]
Lang, Roland [6 ]
Kofler, Barbara [1 ]
机构
[1] Paracelsus Med Univ, Univ Hosp, Res Program Receptor Biochem & Tumor Metab, Dept Pediat, A-5020 Salzburg, Austria
[2] Biocrates Life Sci AG, A-6020 Innsbruck, Austria
[3] Univ Catholique Louvain UCLouvain, Inst Rech Expt & Clin IREC, B-1200 Brussels, Belgium
[4] Patholab Salzburg, A-5020 Salzburg, Austria
[5] Paracelsus Med Univ, Dept Lab Med, Univ Hosp, A-5020 Salzburg, Austria
[6] Paracelsus Med Univ, Univ Hosp, Dept Dermatol & Allergol, A-5020 Salzburg, Austria
基金
欧盟地平线“2020”; 奥地利科学基金会;
关键词
Ketogenic diet; Melanoma; Cancer metabolism; Metabolomics; AMINO-ACID-METABOLISM; PANCREATICOBILIARY CANCER; CELL; SPHINGOMYELIN; INTERVENTION; INHIBITION; MECHANISMS; EXPRESSION; BIOMARKERS; KETOSIS;
D O I
10.1186/s40170-022-00288-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Growing evidence supports the use of low-carbohydrate/high-fat ketogenic diets as an adjunctive cancer therapy. However, it is unclear which genetic, metabolic, or immunological factors contribute to the beneficial effect of ketogenic diets. Therefore, we investigated the effect of ketogenic diets on the progression and metabolism of genetically and metabolically heterogeneous melanoma xenografts, as well as on the development of melanoma metastases in mice with a functional immune system. Methods Mice bearing BRAF mutant, NRAS mutant, and wild-type melanoma xenografts as well as mice bearing highly metastatic melanoma allografts were fed with a control diet or ketogenic diets, differing in their triglyceride composition, to evaluate the effect of ketogenic diets on tumor growth and metastasis. We performed an in-depth targeted metabolomics analysis in plasma and xenografts to elucidate potential antitumor mechanisms in vivo. Results We show that ketogenic diets effectively reduced tumor growth in immunocompromised mice bearing genetically and metabolically heterogeneous human melanoma xenografts. Furthermore, the ketogenic diets exerted a metastasis-reducing effect in the immunocompetent syngeneic melanoma mouse model. Targeted analysis of plasma and tumor metabolomes revealed that ketogenic diets induced distinct changes in amino acid metabolism. Interestingly, ketogenic diets reduced the levels of alpha-amino adipic acid, a biomarker of cancer, in circulation to levels observed in tumor-free mice. Additionally, alpha-amino adipic acid was reduced in xenografts by ketogenic diets. Moreover, the ketogenic diets increased sphingomyelin levels in plasma and the hydroxylation of sphingomyelins and acylcarnitines in tumors. Conclusions Ketogenic diets induced antitumor effects toward melanoma regardless of the tumors ' genetic background, its metabolic signature, and the host immune status. Moreover, ketogenic diets simultaneously affected multiple metabolic pathways to create an unfavorable environment for melanoma cell proliferation, supporting their potential as a complementary nutritional approach to melanoma therapy.
引用
收藏
页数:20
相关论文
共 59 条
  • [1] Genomic Classification of Cutaneous Melanoma
    Akbani, Rehan
    Akdemir, Kadir C.
    Aksoy, B. Arman
    Albert, Monique
    Ally, Adrian
    Amin, Samirkumar B.
    Arachchi, Harindra
    Arora, Arshi
    Auman, J. Todd
    Ayala, Brenda
    Baboud, Julien
    Balasundaram, Miruna
    Balu, Saianand
    Barnabas, Nandita
    Bartlett, John
    Bartlett, Pam
    Bastian, Boris C.
    Baylin, Stephen B.
    Behera, Madhusmita
    Belyaev, Dmitry
    Benz, Christopher
    Bernard, Brady
    Beroukhim, Rameen
    Bir, Natalie
    Black, Aaron D.
    Bodenheimer, Tom
    Boice, Lori
    Boland, Genevieve M.
    Bono, Riccardo
    Bootwalla, Moiz S.
    Bosenberg, Marcus
    Bowen, Jay
    Bowlby, Reanne
    Bristow, Christopher A.
    Brockway-Lunardi, Laura
    Brooks, Denise
    Brzezinski, Jakub
    Bshara, Wiam
    Buda, Elizabeth
    Burns, William R.
    Butterfield, Yaron S. N.
    Button, Michael
    Calderone, Tiffany
    Cappellini, Giancarlo Antonini
    Carter, Candace
    Carter, Scott L.
    Cherney, Lynn
    Cherniack, Andrew D.
    Chevalier, Aaron
    Chin, Lynda
    [J]. CELL, 2015, 161 (07) : 1681 - 1696
  • [2] Targeting Mitochondria in Melanoma
    Aminzadeh-Gohari, Sepideh
    Weber, Daniela D.
    Catalano, Luca
    Feichtinger, Rene G.
    Kofler, Barbara
    Lang, Roland
    [J]. BIOMOLECULES, 2020, 10 (10) : 1 - 21
  • [3] A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model
    Aminzadeh-Gohari, Sepideh
    Feichtinger, Rene Guenther
    Vidali, Silvia
    Locker, Felix
    Rutherford, Tricia
    O'Donnel, Maura
    Stoger-Kleiber, Andrea
    Mayr, Johannes Adalbert
    Sperl, Wolfgang
    Kofler, Barbara
    [J]. ONCOTARGET, 2017, 8 (39) : 64728 - 64744
  • [4] Branched-chain amino acid metabolism in cancer
    Ananieva, Elitsa A.
    Wilkinson, Adam C.
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2018, 21 (01) : 64 - 70
  • [5] Oncosecretomics coupled to bioenergetics identifies α-amino adipic acid, isoleucine and GABA as potential biomarkers of cancer: Differential expression of c-Myc, Oct1 and KLF4 coordinates metabolic changes
    Bellance, Nadege
    Pabst, Lisa
    Allen, Genevara
    Rossignol, Rodrigue
    Nagrath, Deepak
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2012, 1817 (11): : 2060 - 2071
  • [6] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [7] Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma
    Bilal, Fatima
    Montfort, Anne
    Gilhodes, Julia
    Garcia, Virginie
    Riond, Joelle
    Carpentier, Stephane
    Filleron, Thomas
    Colacios, Celine
    Levade, Thierry
    Daher, Ahmad
    Meyer, Nicolas
    Andrieu-Abadie, Nathalie
    Segui, Bruno
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [8] Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86
  • [9] A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer
    Cohen, Caroline W.
    Fontaine, Kevin R.
    Arend, Rebecca C.
    Alvarez, Ronald D.
    Leath, Charles A., III
    Huh, Warner K.
    Bevis, Kerni S.
    Kim, Kenneth H.
    Straughn, John M., Jr.
    Gower, Barbara A.
    [J]. JOURNAL OF NUTRITION, 2018, 148 (08) : 1253 - 1260
  • [10] Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas
    de Groot, Evelyn
    Varghese, Sruthy
    Tan, Lin
    Knighton, Barbara
    Sobieski, Mary
    Nguyen, Nghi
    Park, Yong Sung
    Powell, Reid
    Lorenzi, Philip L.
    Zheng, Bin
    Stephan, Clifford
    Gopal, Y. N. Vashisht
    [J]. CANCER & METABOLISM, 2022, 10 (01)